Metabolic-Associated Steatotic Liver Disease (MASLD): A New Term for a More Appropriate Therapy in Pediatrics?

Mosca AntonellaAndrea Pietrobattista Giuseppe Maggiore

Published in: Pediatric reports (2024)

The term "non-alcoholic fatty liver disease" (NAFLD) has been, for a long time, used to describe the spectrum of liver lesions encompassing steatosis, steatohepatitis (NASH), and steatotic cirrhosis [...].

Keyphrases

preterm infants
gestational age
liver fibrosis
insulin resistance
high fat diet
high fat diet induced
preterm birth
mesenchymal stem cells
skeletal muscle
cell therapy
replacement therapy